Suppr超能文献

二聚化导致 APP(淀粉样前体蛋白)通过 LRP1 和 SorLA 介导的运输发生变化。

Dimerization leads to changes in APP (amyloid precursor protein) trafficking mediated by LRP1 and SorLA.

机构信息

Department of Human Biology and Human Genetics, University of Kaiserslautern, Erwin-Schrödinger-Str. 13, 67663, Kaiserslautern, Germany.

Institute for Biochemistry, Christian Albrechts University Kiel, 24118, Kiel, Germany.

出版信息

Cell Mol Life Sci. 2018 Jan;75(2):301-322. doi: 10.1007/s00018-017-2625-7. Epub 2017 Aug 10.

Abstract

Proteolytic cleavage of the amyloid precursor protein (APP) by α-, β- and γ-secretases is a determining factor in Alzheimer's disease (AD). Imbalances in the activity of all three enzymes can result in alterations towards pathogenic Aβ production. Proteolysis of APP is strongly linked to its subcellular localization as the secretases involved are distributed in different cellular compartments. APP has been shown to dimerize in cis-orientation, affecting Aβ production. This might be explained by different substrate properties defined by the APP oligomerization state or alternatively by altered APP monomer/dimer localization. We investigated the latter hypothesis using two different APP dimerization systems in HeLa cells. Dimerization caused a decreased localization of APP to the Golgi and at the plasma membrane, whereas the levels in the ER and in endosomes were increased. Furthermore, we observed via live cell imaging and biochemical analyses that APP dimerization affects its interaction with LRP1 and SorLA, suggesting that APP dimerization modulates its interplay with sorting molecules and in turn its localization and processing. Thus, pharmacological approaches targeting APP oligomerization properties might open novel strategies for treatment of AD.

摘要

淀粉样前体蛋白(APP)的蛋白水解由 α-、β-和 γ-分泌酶切割,这是阿尔茨海默病(AD)的决定因素。三种酶的活性失衡可能导致致病性 Aβ 产生的改变。APP 的蛋白水解与它的亚细胞定位密切相关,因为涉及的分泌酶分布在不同的细胞区室中。已经表明 APP 以顺式取向二聚化,影响 Aβ 的产生。这可以通过 APP 寡聚化状态定义的不同底物特性来解释,或者通过改变 APP 单体/二聚体定位来解释。我们使用 HeLa 细胞中的两种不同的 APP 二聚化系统研究了后一种假设。二聚化导致 APP 向高尔基体和质膜的定位减少,而内质网和内体中的水平增加。此外,我们通过活细胞成像和生化分析观察到 APP 二聚化影响其与 LRP1 和 SorLA 的相互作用,表明 APP 二聚化调节其与分拣分子的相互作用,进而调节其定位和加工。因此,针对 APP 寡聚化特性的药理学方法可能为 AD 的治疗开辟新的策略。

相似文献

引用本文的文献

9
The apolipoprotein receptor LRP3 compromises APP levels.载脂蛋白受体 LRP3 影响 APP 水平。
Alzheimers Res Ther. 2021 Nov 2;13(1):181. doi: 10.1186/s13195-021-00921-5.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验